193 related articles for article (PubMed ID: 15314683)
1. The T cell cometh: interplay between adaptive immunity and cytokine networks in rheumatoid arthritis.
Firestein GS
J Clin Invest; 2004 Aug; 114(4):471-4. PubMed ID: 15314683
[TBL] [Abstract][Full Text] [Related]
2. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
Sebbag M; Parry SL; Brennan FM; Feldmann M
Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
[TBL] [Abstract][Full Text] [Related]
3. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
4. Exploring the reciprocal relationship between immunity and inflammation in chronic inflammatory arthritis.
Cope AP
Rheumatology (Oxford); 2003 Jun; 42(6):716-31. PubMed ID: 12730506
[TBL] [Abstract][Full Text] [Related]
5. Perspective of cytokine regulation for periodontal treatment: fibroblast biology.
Takashiba S; Naruishi K; Murayama Y
J Periodontol; 2003 Jan; 74(1):103-10. PubMed ID: 12593604
[TBL] [Abstract][Full Text] [Related]
6. The TNF-alpha transgenic mouse model of inflammatory arthritis.
Li P; Schwarz EM
Springer Semin Immunopathol; 2003 Aug; 25(1):19-33. PubMed ID: 12904889
[TBL] [Abstract][Full Text] [Related]
7. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice.
Sakaguchi N; Takahashi T; Hata H; Nomura T; Tagami T; Yamazaki S; Sakihama T; Matsutani T; Negishi I; Nakatsuru S; Sakaguchi S
Nature; 2003 Nov; 426(6965):454-60. PubMed ID: 14647385
[TBL] [Abstract][Full Text] [Related]
8. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Williams RO; Paleolog E; Feldmann M
Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
[TBL] [Abstract][Full Text] [Related]
9. Thymus, innate immunity and autoimmune arthritis: interplay of gene and environment.
Sakaguchi S; Tanaka S; Tanaka A; Ito Y; Maeda S; Sakaguchi N; Hashimoto M
FEBS Lett; 2011 Dec; 585(23):3633-9. PubMed ID: 22027617
[TBL] [Abstract][Full Text] [Related]
10. Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action.
Feldmann M; Brennan FM; Williams RO; Elliott MJ; Maini RN
J Inflamm; 1995-1996; 47(1-2):90-6. PubMed ID: 8913935
[TBL] [Abstract][Full Text] [Related]
11. Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis.
Roord ST; Zonneveld-Huijssoon E; Le T; Yung GP; Koffeman E; Ronaghy A; Ghahramani N; Lanza P; Billetta R; Prakken BJ; Albani S
PLoS One; 2006 Dec; 1(1):e87. PubMed ID: 17183718
[TBL] [Abstract][Full Text] [Related]
12. Immunological therapies for rheumatoid arthritis.
Edwards CJ
Br Med Bull; 2005; 73-74():71-82. PubMed ID: 16174791
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
14. TNF alpha as a therapeutic target in rheumatoid arthritis.
Feldmann M; Brennan FM; Elliott M; Katsikis P; Maini RN
Circ Shock; 1994 Aug; 43(4):179-84. PubMed ID: 7895323
[TBL] [Abstract][Full Text] [Related]
15. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
Saxena N; Aggarwal A; Misra R
J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
[TBL] [Abstract][Full Text] [Related]
16. Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Lawlor KE; Wong PK; Campbell IK; van Rooijen N; Wicks IP
Arthritis Rheum; 2005 Dec; 52(12):3749-54. PubMed ID: 16320325
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis.
Lorenzo N; Barberá A; Domínguez MC; Torres AM; Hernandez MV; Hernandez I; Gil R; Ancizar J; Garay H; Reyes O; Altruda F; Silengo L; Padrón G
Autoimmunity; 2012 Sep; 45(6):449-59. PubMed ID: 22686732
[TBL] [Abstract][Full Text] [Related]
18. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
[TBL] [Abstract][Full Text] [Related]
19. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
[TBL] [Abstract][Full Text] [Related]
20. Cytokines and cellular interactions in inflammatory synovitis.
Arend WP
J Clin Invest; 2001 May; 107(9):1081-2. PubMed ID: 11342571
[No Abstract] [Full Text] [Related]
[Next] [New Search]
